Table of Contents Author Guidelines Submit a Manuscript
Journal of Aging Research
Volume 2014, Article ID 153127, 14 pages
http://dx.doi.org/10.1155/2014/153127
Review Article

Efficacy of Female Rat Models in Translational Cardiovascular Aging Research

1Center for Diagnostic Nanosystems and Robert C. Byrd Biotechnology Science Center, Marshall University, Room 241D, 1700 3rd Avenue, Huntington, WV 25755-1090, USA
2Department of Pharmacology, Physiology and Toxicology, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV, USA
3Department of Pharmacy Practice, Administration, and Research, School of Pharmacy, Marshall University, Huntington, WV, USA
4Department of Pharmaceutical Sciences and Research, School of Pharmacy, Marshall University, Huntington, WV, USA

Received 14 August 2014; Revised 5 December 2014; Accepted 5 December 2014; Published 31 December 2014

Academic Editor: F. R. Ferraro

Copyright © 2014 K. M. Rice et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Johannes and C. N. Bairey Merz, “Is cardiovascular disease in women inevitable?: preparing for menopause and beyond,” Cardiology in Review, vol. 19, no. 2, pp. 76–80, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Yazdanyar and A. B. Newman, “The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs,” Clinics in Geriatric Medicine, vol. 25, no. 4, pp. 563–577, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Heart disease and stroke statistics—2013 update: a report from the American Heart Association,” Circulation, vol. 127, no. 1, pp. e6–e245, 2013. View at Publisher · View at Google Scholar
  4. E. G. Lakatta, “Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging,” Circulation, vol. 107, no. 3, pp. 490–497, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Anna, D. R. Riordon, and K. Boheler, “Molecular mechanisms of cardiomyocyte aging,” Clinical Science, vol. 121, no. 8, pp. 315–329, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Hatch, M. K. Lancaster, and S. A. Jones, “Aging is a primary risk factor for cardiac arrhythmias: disruption of intracellular Ca2+ regulation as a key suspect,” Expert Review of Cardiovascular Therapy, vol. 9, no. 8, pp. 1059–1067, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Karavidas, G. Lazaros, D. Tsiachris, and V. Pyrgakis, “Aging and the cardiovascular system,” Hellenic Journal of Cardiology, vol. 51, no. 5, pp. 421–427, 2010. View at Google Scholar · View at Scopus
  8. W. Rosamond, K. Flegal, K. Furie et al., “Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee,” Circulation, vol. 117, no. 4, pp. e25–e146, 2008. View at Google Scholar
  9. L. Mosca, J. E. Manson, S. E. Sutherland, R. D. Langer, T. Manolio, and E. Barrett-Connor, “Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group.,” Circulation, vol. 96, no. 7, pp. 2468–2482, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Okura, Y. Takada, A. Yamabe et al., “Age-and gender-specific changes in the left ventricular relaxation a doppler echocardiographic study in healthy individuals,” Circulation: Cardiovascular Imaging, vol. 2, no. 1, pp. 41–46, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. C. G. Frazier, K. P. Alexander, L. K. Newby et al., “Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials,” Journal of the American College of Cardiology, vol. 49, no. 13, pp. 1450–1458, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. C. D. Kimmelstiel and M. A. Konstam, “Heart failure in women,” Cardiology, vol. 86, no. 4, pp. 304–309, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Shapira, A. Isakov, and M. Burke, “Cardiac rupture in patients with acute myocardial infarction,” Chest, vol. 92, no. 2, pp. 219–223, 1987. View at Publisher · View at Google Scholar · View at Scopus
  14. J. D. Carroll, E. P. Carroll, T. Feldman et al., “Sex-associated differences in left ventricular function in aortic stenosis of the elderly,” Circulation, vol. 86, no. 4, pp. 1099–1107, 1992. View at Publisher · View at Google Scholar · View at Scopus
  15. C. S. Hayward, R. P. Kelly, and P. Collins, “The roles of gender, the menopause and hormone replacement on cardiovascular function,” Cardiovascular Research, vol. 46, no. 1, pp. 28–49, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Klein, C. Kortan, D. I. Kells, and K. J. Dorrington, “Equilibrium and kinetic aspects of the interaction of isolated variable and constant domains of light chain with the Fd' fragment of immunoglobulin G,” Biochemistry, vol. 18, no. 8, pp. 1473–1481, 1979. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Jousilahti, E. Vartiainen, J. Tuomilehto, and P. Puska, “Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland,” Circulation, vol. 99, no. 9, pp. 1165–1172, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. S. D. Kafonek, “Postmenopausal hormone replacement therapy and cardiovascular risk reduction. A review,” Drugs, vol. 47, supplement, no. 2, pp. 16–24, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. J. de Kleijn, Y. T. van der Schouw, A. L. M. Verbeek, P. H. M. Peeters, J.-D. Banga, and Y. van der Graaf, “Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women,” American Journal of Epidemiology, vol. 155, no. 4, pp. 339–345, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. B. K. Jacobsen, S. Nilssen, I. Heuch, and G. Kvåle, “Does age at natural menopause affect mortality from ischemic heart disease?” Journal of Clinical Epidemiology, vol. 50, no. 4, pp. 475–479, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. F. B. Hu, F. Grodstein, C. H. Hennekens et al., “Age at natural menopause and risk of cardiovascular disease,” Archives of Internal Medicine, vol. 159, no. 10, pp. 1061–1066, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. V. L. Jacoby, D. Grady, and G. F. Sawaya, “Oophorectomy as a risk factor for coronary heart disease,” American Journal of Obstetrics & Gynecology, vol. 200, no. 2, pp. 140.e1–140.e9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. T. van der Schouw, Y. van der Graaf, E. W. Steyerberg, M. J. C. Eijkemans, and J. D. Banga, “Age at menopause as a risk factor for cardiovascular mortality,” The Lancet, vol. 347, no. 9003, pp. 714–718, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. K. H. Lu, B. R. Hopper, T. M. Vargo, and S. S. C. Yen, “Chronological changes in sex steroid, gonadotropin and prolactin secretion in aging female rats displaying different reproductive states,” Biology of Reproduction, vol. 21, no. 1, pp. 193–203, 1979. View at Publisher · View at Google Scholar · View at Scopus
  25. S. C. Alberts, J. Altmannb, D. K. Brockman et al., “Reproductive aging patterns in primates reveal that humans are distinct,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 33, pp. 13440–13445, 2013. View at Publisher · View at Google Scholar
  26. V. Ledvenyiova, D. Pancza, J. Matejiková, M. Ferko, I. Bernatova, and T. Ravingerova, “Impact of age and sex on response to ischemic preconditioning in the rat heart: differential role of the PI3K-AKT pathway,” Canadian Journal of Physiology and Pharmacology, vol. 91, no. 8, pp. 640–647, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. G. C. S. V. Tezini, C. Becari, C. Z. Zanotto, M. C. O. Salgado, R. D. C. A. T. Passaglia, and H. C. D. Souza, “Ageing is the main determinant of haemodynamics and autonomic cardiac changes observed in post-menopausal female rats,” Autonomic Neuroscience: Basic and Clinical, vol. 174, no. 1-2, pp. 36–41, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. S. G. Campbell, P. Haynes, W. K. Snapp, K. E. Nava, and K. S. Campbell, “Altered ventricular torsion and transmural patterns of myocyte relaxation precede heart failure in aging F344 rats,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 305, no. 5, pp. H676–H686, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. T. S. Lancaster, S. J. Jefferson, J. G. Hunter et al., “Quantitative proteomic analysis reveals novel mitochondrial targets of estrogen deficiency in the aged female rat heart,” Physiological Genomics, vol. 44, no. 20, pp. 957–969, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. N. M. Tenõrio, S. Tufik, C. T. Bergamaschi et al., “Influence of acute sleep deprivation on cardiovascular parameters in female zucker obese and lean rats,” Obesity, vol. 21, no. 3, pp. 510–515, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. J. W. Simpkins, H. H. Huang, J. P. Advis, and J. Meites, “Changes in hypothalamic NE and DA turnover resulting from steroid-induced LH and prolactin surges in ovariectomized rats,” Biology of Reproduction, vol. 20, no. 3, pp. 625–632, 1979. View at Publisher · View at Google Scholar · View at Scopus
  32. J. P. Advis, J. W. Simpkins, H. T. Chen, and J. Meites, “Relation of biogenic amines to onset of puberty in the female rat,” Endocrinology, vol. 103, no. 1, pp. 11–16, 1978. View at Publisher · View at Google Scholar · View at Scopus
  33. J. I. Acosta, L. Mayer, J. S. Talboom et al., “Transitional versus surgical menopause in a rodent model: etiology of ovarian hormone loss impacts memory and the acetylcholine system,” Endocrinology, vol. 150, no. 9, pp. 4248–4259, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. T. A. Van Kempen, T. A. Milner, and E. M. Waters, “Accelerated ovarian failure: a novel, chemically induced animal model of menopause,” Brain Research, vol. 1379, pp. 176–187, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. C. J. Kappeler and P. B. Hoyer, “4-vinylcyclohexene diepoxide: A model chemical for ovotoxicity,” Systems Biology in Reproductive Medicine, vol. 58, no. 1, pp. 57–62, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. J. A. Parrott and M. K. Skinner, “Kit-ligand/stem cell factor induces primordial follicle development and initiates folliculogenesis,” Endocrinology, vol. 140, no. 9, pp. 4262–4271, 1999. View at Google Scholar · View at Scopus
  37. X. Jin, C.-S. Han, F.-Q. Yu, P. Wei, Z.-Y. Hu, and Y.-X. Liu, “Anti-apoptotic action of stem cell factor on oocytes in primordial follicles and its signal transduction,” Molecular Reproduction and Development, vol. 70, no. 1, pp. 82–90, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. J. B. Frye, A. L. Lukefahr, L. E. Wright, S. L. Marion, P. B. Hoyer, and J. L. Funk, “Modeling perimenopause in sprague-dawley rats by chemical manipulation of the transition to ovarian failure,” Comparative Medicine, vol. 62, no. 3, pp. 193–202, 2012. View at Google Scholar · View at Scopus
  39. T. Kodama, J. Yoshida, T. Miwa, D. Hasegawa, and T. Masuyama, “Collaborative work on evaluation of ovarian toxicity. 4) Effects of fertility study of 4-vinylcyclohexene diepoxide in female rats,” Journal of Toxicological Sciences, vol. 34, supplement 1, pp. SP59–SP63, 2009. View at Google Scholar · View at Scopus
  40. A. Ito, N. Mafune, and T. Kimura, “Collaborative work on evaluation of ovarian toxicity 4) Two- or four-week repeated dose study of 4-vinylcyclohexene diepoxide in female rats,” The Journal of Toxicological Sciences, vol. 34, no. 1, pp. SP53–SP58, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. F. S. Muhammad, A. K. Goode, N. D. Kock et al., “Effects of 4-vinylcyclohexene diepoxide on peripubertal and adult sprague-dawley Rats: ovarian, clinical, and pathologic outcomes,” Comparative Medicine, vol. 59, no. 1, pp. 46–59, 2009. View at Google Scholar · View at Scopus
  42. R. A. Lobo, “Surgical menopause and cardiovascular risks,” Menopause, vol. 14, no. 3, part 2, pp. 562–566, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. L. T. Shuster, B. S. Gostout, B. R. Grossardt, and W. A. Rocca, “Prophylactic oophorectomy in premenopausal women and long-term health,” Menopause International, vol. 14, no. 3, pp. 111–116, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Özkaya, E. Çakr, E. Okuyan, C. Çakr, G. Üstün, and T. Küçüközkan, “Comparison of the effects of surgical and natural menopause on carotid intima media thickness, osteoporosis, and homocysteine levels,” Menopause, vol. 18, no. 1, pp. 73–76, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. J. H. Morrison, R. D. Brinton, P. J. Schmidt, and A. C. Gore, “Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women,” The Journal of Neuroscience, vol. 26, no. 41, pp. 10332–10348, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. W. A. Rocca, B. R. Grossardt, and L. T. Shuster, “Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis,” Neurodegenerative Diseases, vol. 7, no. 1–3, pp. 163–166, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. S. D. Lee, W.-W. Kuo, Y.-J. Ho et al., “Cardiac Fas-dependent and mitochondria-dependent apoptosis in ovariectomized rats,” Maturitas, vol. 61, no. 3, pp. 268–277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. J. P. Stice, L. Chen, S.-C. Kim et al., “17β-estradiol, aging, inflammation, and the stress response in the female heart,” Endocrinology, vol. 152, no. 4, pp. 1589–1598, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. I. Baeza, J. Fdez-Tresguerres, C. Ariznavarreta, and M. de la Fuente, “Effects of growth hormone, melatonin, oestrogens and phytoestrogens on the oxidized glutathione (GSSG)/reduced glutathione (GSH) ratio and lipid peroxidation in aged ovariectomized rats,” Biogerontology, vol. 11, no. 6, pp. 687–701, 2010. View at Publisher · View at Google Scholar
  50. B. Fabris, R. Candido, M. Bortoletto et al., “Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin-angiotensin system,” Journal of Hypertension, vol. 29, no. 2, pp. 273–281, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. C.-M. Liou, A.-L. Yang, C.-H. Kuo, H. Tin, C.-Y. Huang, and S.-D. Lee, “Effects of 17beta-estradiol on cardiac apoptosis in ovariectomized rats,” Cell Biochemistry and Function, vol. 28, no. 6, pp. 521–528, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Hinojosa-Laborde, T. Craig, W. Zheng, H. Ji, J. R. Haywood, and K. Sandberg, “Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats,” Hypertension, vol. 44, no. 4, pp. 405–409, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. J. F. Reckelhoff, “Sex steroids, cardiovascular disease, and hypertension: unanswered questions and some speculations,” Hypertension, vol. 45, no. 2, pp. 170–174, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. J. P. Stice, J. S. Lee, A. S. Pechenino, and A. A. Knowlton, “Estrogen, aging and the cardiovascular system,” Future Cardiology, vol. 5, no. 1, pp. 93–103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. O. M. Kharchilava and L. A. Valeeva, “Effects of surgical ovariectomy on dopamine receptors of the heart and brain,” Patologicheskaia Fiziologiia i Èksperimental'naia Terapiia, no. 4, pp. 21–23, 2008. View at Google Scholar · View at Scopus
  56. M. O. Verhoeven, M. J. Van Der Mooren, T. Teerlink, R. H. M. Verheijen, P. G. Scheffer, and P. Kenemans, “The influence of physiological and surgical menopause on coronary heart disease risk markers,” Menopause, vol. 16, no. 1, pp. 37–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. C. M. Wong, X. Yao, C. L. Au et al., “Raloxifene prevents endothelial dysfunction in aging ovariectomized female rats,” Vascular Pharmacology, vol. 44, no. 5, pp. 290–298, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. G. Olivetti, G. Giordano, D. Corradi et al., “Gender differences and aging: effects on the human heart,” Journal of the American College of Cardiology, vol. 26, no. 4, pp. 1068–1079, 1995. View at Publisher · View at Google Scholar · View at Scopus
  59. A. L. Danneberg, D. Levy, and R. J. Garrison, “Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham Study),” American Journal of Cardiology, vol. 64, no. 16, pp. 1066–1068, 1989. View at Publisher · View at Google Scholar · View at Scopus
  60. A. S. Go, “The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg,” The American Journal of Geriatric Cardiology, vol. 14, no. 2, pp. 56–61, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. M. O. Boluyt, K. Converso, H. S. Hwang, A. Mikkor, and M. W. Russell, “Echocardiographic assessment of age-associated changes in systolic and diastolic function of the female F344 rat heart,” Journal of Applied Physiology, vol. 96, no. 2, pp. 822–828, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. M. O. Boluyt, S. T. Devor, J. A. Opiteck, and T. P. White, “Regional variation in cardiac myosin isoforms of female F344 rats during aging,” Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 54, no. 8, pp. B313–B317, 1999. View at Publisher · View at Google Scholar · View at Scopus
  63. M. O. Boluyt, J. A. Opiteck, K. A. Esser, and T. P. White, “Cardiac adaptations to aortic constriction in adult and aged rats,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 257, no. 2, pp. H643–H648, 1989. View at Google Scholar · View at Scopus
  64. S. Miyata, W. Minobe, M. R. Bristow, and L. A. Leinwand, “Myosin heavy chain isoform expression in the failing and nonfailing human heart,” Circulation Research, vol. 86, no. 4, pp. 386–390, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Fannin, K. M. Rice, S. Thulluri et al., “Age-associated alterations of cardiac structure and function in the female F344xBN rat heart,” AGE, vol. 36, article 9684, 2014. View at Publisher · View at Google Scholar
  66. D. R. Meldrum, M. Wang, B. M. Tsai et al., “Intracellular signaling mechanisms of sex hormones in acute myocardial inflammation and injury,” Frontiers in Bioscience, vol. 10, no. 2, pp. 1835–1867, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. A. K. Gupta, A. Maheshwari, D. D. Tresch, and R. K. Thakur, “Cardiac arrhythmias in the elderly,” Cardiac Electrophysiology Review, vol. 6, no. 1-2, pp. 120–128, 2002. View at Publisher · View at Google Scholar
  68. S. Rossi, S. Baruffi, A. Bertuzzi et al., “Ventricular activation is impaired in aged rat hearts,” The American Journal of Physiology: Heart and Circulatory Physiology, vol. 295, no. 6, pp. H2336–H2347, 2008. View at Publisher · View at Google Scholar
  69. S. Xing, S.-W. Tsaih, R. Yuan et al., “Genetic influence on electrocardiogram time intervals and heart rate in aging mice,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 296, no. 6, pp. H1907–H1913, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. V. J. D. da Silva, E. F. Neto, H. C. Salgado, and R. F. Júnior, “Chronic converting enzyme inhibition normalizes QT interval in aging rats,” Brazilian Journal of Medical and Biological Research, vol. 35, no. 9, pp. 1025–1031, 2002. View at Google Scholar · View at Scopus
  71. U. Molander, D. K. Dey, V. Sundh, and B. Steen, “ECG abnormalities in the elderly: prevalence, time and generation trends and association with mortality,” Aging Clinical and Experimental Research, vol. 15, no. 6, pp. 488–493, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. A. F. James, S. C. M. Choisy, and J. C. Hancox, “Recent advances in understanding sex differences in cardiac repolarization,” Progress in Biophysics and Molecular Biology, vol. 94, no. 3, pp. 265–319, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. P. W. Macfarlane, S. C. McLaughlin, B. Devine, and T. F. Yang, “Effects of age, sex, and race on ECG interval measurements,” Journal of Electrocardiology, vol. 27, pp. 14–19, 1994. View at Publisher · View at Google Scholar · View at Scopus
  74. T. Taneja, B. W. Mahnert, R. O. D. Passman, J. Goldberger, and A. Kadish, “Effects of sex and age on electrocardiographic and cardiac electrophysiological properties in adults,” PACE-Pacing and Clinical Electrophysiology, vol. 24, no. 1, pp. 16–21, 2001. View at Publisher · View at Google Scholar · View at Scopus
  75. D. Levy, J. J. Bailey, R. J. Garrison et al., “Electrocardiographic changes with advancing age. A cross-sectional study of the association of age with QRS axis, duration and voltage,” Journal of Electrocardiology, vol. 20, pp. 44–47, 1987. View at Google Scholar · View at Scopus
  76. P. Rautaharju, S. H. Zhou, S. Wong et al., “Sex differences in the evolution of the electrocardiographic QT interval with age,” Canadian Journal of Cardiology, vol. 8, no. 7, pp. 690–695, 1992. View at Google Scholar · View at Scopus
  77. R. J. Pocchiari, R. L. Hamlin, and S. A. McCune, “Electrocardiographic findings in rats with cardiomyopathy,” The American Journal of Veterinary Research, vol. 54, no. 4, pp. 607–611, 1993. View at Google Scholar · View at Scopus
  78. I. Netuka, O. Szárszoi, J. Malý et al., “Late effect of early hypoxic disturbance in the rat heart: gender differences,” Physiological Research, vol. 59, no. 1, pp. 127–131, 2010. View at Google Scholar · View at Scopus
  79. J. A. Wasserstrom, S. Kapur, S. Jones et al., “Characteristics of intracellular Ca2+ cycling in intact rat heart: a comparison of sex differences,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 295, no. 5, pp. H1895–H1904, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. K. L. Philp, M. Hussain, N. F. Byrne, M. J. Diver, G. Hart, and S. J. Coker, “Greater antiarrhythmic activity of acute 17β-estradiol in female than male anaesthetized rats: correlation with Ca2+ channel blockade,” British Journal of Pharmacology, vol. 149, no. 3, pp. 233–242, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. C. Jiang, P. A. Poole-Wilson, P. M. Sarrel, S. Mochizuki, P. Collins, and K. T. MacLeod, “Effect of 17β-oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes,” British Journal of Pharmacology, vol. 106, no. 3, pp. 739–745, 1992. View at Publisher · View at Google Scholar · View at Scopus
  82. ICH, “Guidance for industry: S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals,” in Proceedings of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH '05), U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), and Center for Biologics Evaluation and Research (CBER), Eds., pp. 1–10, Rockville, Md, USA, 2005.
  83. L. K. Bhatt, K. Nandakumar, and S. L. Bodhankar, “Experimental animal models to induce cardiac arrhythmias,” Indian Journal of Pharmacology, vol. 37, no. 6, pp. 348–357, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. W. E. Louch, M. K. Stokke, I. Sjaastad, G. Christensen, and O. M. Sejersted, “No rest for the weary: diastolic calcium homeostasis in the normal and failing myocardium,” Physiology, vol. 27, no. 5, pp. 308–323, 2012. View at Publisher · View at Google Scholar · View at Scopus
  85. S. J. Shipsey, S. M. Bryant, and G. Hart, “Effects of hypertrophy on regional action potential characteristics in the rat left ventricle: a cellular basis for T-wave inversion?” Circulation, vol. 96, no. 6, pp. 2061–2068, 1997. View at Publisher · View at Google Scholar · View at Scopus
  86. Z. Tatarková, S. Kuka, P. Račay et al., “Effects of aging on activities of mitochondrial electron transport chain complexes and oxidative damage in rat heart,” Physiological Research, vol. 60, no. 2, pp. 281–289, 2011. View at Google Scholar · View at Scopus
  87. H. Huang and K. G. Manton, “The role of oxidative damage in mitochondria during aging: a review,” Frontiers in Bioscience, vol. 9, pp. 1100–1117, 2004. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Asano, K. M. Rice, S. Kakarla et al., “Aging influences multiple indices of oxidative stress in the heart of the Fischer 344/NNia x Brown Norway/BiNia rat,” Redox Report, vol. 12, no. 4, pp. 167–180, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. R. Kayali, U. Çakatay, H. Uzun, and H. Genç, “Gender difference as regards myocardial protein oxidation in aged rats: male rats have increased oxidative protein damage,” Biogerontology, vol. 8, no. 6, pp. 653–661, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. B. Colom, J. Oliver, P. Roca, and F. J. Garcia-Palmer, “Caloric restriction and gender modulate cardiac muscle mitochondrial H2O2 production and oxidative damage,” Cardiovascular Research, vol. 74, no. 3, pp. 456–465, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. C. Borrás, J. Sastre, D. García-Sala, A. Lloret, F. V. Pallardó, and J. Viña, “Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males,” Free Radical Biology & Medicine, vol. 34, no. 5, pp. 546–552, 2003. View at Publisher · View at Google Scholar · View at Scopus
  92. Y. M. Jang, S. Kendaiah, B. Drew et al., “Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats,” FEBS Letters, vol. 577, no. 3, pp. 483–490, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. M. Strniskova, M. Barancik, and T. Ravingerova, “Mitogen-activated protein kinases and their role in regulation of cellular processes,” General Physiology and Biophysics, vol. 21, no. 3, pp. 231–255, 2002. View at Google Scholar
  94. T. P. Garrington and G. L. Johnson, “Organization and regulation of mitogen-activated protein kinase signaling pathways,” Current Opinion in Cell Biology, vol. 11, no. 2, pp. 211–218, 1999. View at Publisher · View at Google Scholar · View at Scopus
  95. S. L. House, B. E. House, B. Glascock et al., “Fibroblast growth factor 2 mediates isoproterenol-induced cardiac hypertrophy through activation of the extracellular regulated kinase,” Molecular and Cellular Pharmacology, vol. 2, no. 4, pp. 143–154, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. L. E. Lemke, L. J. Bloem, R. Fouts, M. Esterman, G. Sandusky, and C. J. Vlahos, “Decreased p38 MAPK activity in end-stage failing human myocardium: p38 MAPK α is the predominant isoform expressed in human heart,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 8, pp. 1527–1540, 2001. View at Publisher · View at Google Scholar · View at Scopus
  97. C. Communal, W. S. Colucci, A. Remondino et al., “Reciprocal modulation of mitogen-activated protein kinases and mitogen-activated protein kinase phosphatase 1 and 2 in failing human myocardium,” Journal of Cardiac Failure, vol. 8, no. 2, pp. 86–92, 2002. View at Publisher · View at Google Scholar · View at Scopus
  98. J. N. Peart, E. R. Gross, J. P. Headrick, and G. J. Gross, “Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection,” Journal of Molecular and Cellular Cardiology, vol. 42, no. 5, pp. 972–980, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. A. A. Knowlton, P. Brecher, and C. S. Apstein, “Rapid expression of heat shock protein in the rabbit after brief cardiac ischemia,” Journal of Clinical Investigation, vol. 87, no. 1, pp. 139–147, 1991. View at Publisher · View at Google Scholar · View at Scopus
  100. S. Storti, S. Vittorini, M. R. Iascone et al., “Analysis of the variation in the hsp70-1 and hsp90alpha mRNA expression in human myocardial tissue that has undergone surgical stress,” Cell Stress Chaperones, vol. 8, no. 1, pp. 18–25, 2003. View at Google Scholar
  101. I. J. Benjamin and D. R. McMillan, “Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease,” Circulation Research, vol. 83, no. 2, pp. 117–132, 1998. View at Publisher · View at Google Scholar · View at Scopus
  102. M. Tatar, A. A. Khazaeli, and J. W. Curtsinger, “Chaperoning extended life,” Nature, vol. 390, no. 6655, p. 30, 1997. View at Google Scholar · View at Scopus
  103. W. E. Balch, R. I. Morimoto, A. Dillin, and J. W. Kelly, “Adapting proteostasis for disease intervention,” Science, vol. 319, no. 5865, pp. 916–919, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. W. R. Swindell, M. M. Masternak, J. J. Kopchick, C. A. Conover, A. Bartke, and R. A. Miller, “Endocrine regulation of heat shock protein mRNA levels in long-lived dwarf mice,” Mechanisms of Ageing and Development, vol. 130, no. 6, pp. 393–400, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. S. D. Westerheide and R. I. Morimoto, “Heat shock response modulators as therapeutic tools for diseases of protein conformation,” The Journal of Biological Chemistry, vol. 280, no. 39, pp. 33097–33100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  106. J. W. Starnes, A. M. Choilawala, R. P. Taylor, M. J. Nelson, and M. D. Delp, “Myocardial heat shock protein 70 expression in young and old rats after identical exercise programs,” Journals of Gerontology—Series A Biological Sciences and Medical Sciences, vol. 60, no. 8, pp. 963–969, 2005. View at Publisher · View at Google Scholar · View at Scopus
  107. J. M. Lawler, H.-B. Kwak, J.-H. Kim, and M.-H. Suk, “Exercise training inducibility of MnSOD protein expression and activity is retained while reducing prooxidant signaling in the heart of senescent rats,” American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 296, no. 5, pp. R1496–R1502, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. K. C. Kregel, P. L. Moseley, R. Skidmore, J. A. Gutierrez, and V. Guerriero Jr., “HSP70 accumulation in tissues of heat-stressed rats is blunted with advancing age,” Journal of Applied Physiology, vol. 79, no. 5, pp. 1673–1678, 1995. View at Google Scholar · View at Scopus
  109. B. Chandrasekar and G. L. Freeman, “Induction of nuclear factor κB and activation protein 1 in postischemic myocardium,” FEBS Letters, vol. 401, no. 1, pp. 30–34, 1997. View at Publisher · View at Google Scholar · View at Scopus
  110. C. Li, W. Browder, and R. L. Kao, “Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 276, no. 2, pp. H543–H552, 1999. View at Google Scholar · View at Scopus
  111. S. C. Y. Wong, M. Fukuchi, P. Melnyk, I. Rodger, and A. Giaid, “Induction of cyclooxygenase-2 and activation of nuclear factor-κB in myocardium of patients with congestive heart failure,” Circulation, vol. 98, no. 2, pp. 100–103, 1998. View at Publisher · View at Google Scholar · View at Scopus
  112. S. Frantz, D. Fraccarollo, H. Wagner et al., “Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure,” Cardiovascular Research, vol. 57, no. 3, pp. 749–756, 2003. View at Publisher · View at Google Scholar · View at Scopus
  113. M. J. May and S. Ghosh, “Signal transduction through NF-κB,” Immunology Today, vol. 19, no. 2, pp. 80–88, 1998. View at Publisher · View at Google Scholar · View at Scopus
  114. G. Bonizzi and M. Karin, “The two NF-κB activation pathways and their role in innate and adaptive immunity,” Trends in Immunology, vol. 25, no. 6, pp. 280–288, 2004. View at Publisher · View at Google Scholar · View at Scopus
  115. M. Wang, P. Crisostomo, G. M. Wairiuko, and D. R. Meldrum, “Estrogen receptor-α mediates acute myocardial protection in females,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 290, no. 6, pp. H2204–H2209, 2006. View at Publisher · View at Google Scholar · View at Scopus
  116. M. Wang, B. M. Tsai, K. M. Reiger, J. W. Brown, and D. R. Meldrum, “17-β-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia,” Journal of Molecular and Cellular Cardiology, vol. 40, no. 2, pp. 205–212, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. W. Cheng, L. Chen, S. Yang et al., “Puerarin suppresses proliferation of endometriotic stromal cells partly via the MAPK signaling pathway induced by 17ss-estradiol-BSA,” PLoS ONE, vol. 7, no. 9, Article ID e45529, 2012. View at Publisher · View at Google Scholar · View at Scopus
  118. S. Nuedling, S. Kahlert, K. Loebbert, R. Meyer, H. Vetter, and C. Grohé, “Differential effects of 17β-estradiol on mitogen-activated protein kinase pathways in rat cardiomyocytes,” FEBS Letters, vol. 454, no. 3, pp. 271–276, 1999. View at Publisher · View at Google Scholar · View at Scopus
  119. C. S. Watson, A. M. Norfleet, T. C. Pappas, and B. Gametchu, “Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-α,” Steroids, vol. 64, no. 1-2, pp. 5–13, 1999. View at Publisher · View at Google Scholar · View at Scopus
  120. M. van Eickels, C. Grohé, J. P. M. Cleutjens, B. J. Janssen, H. J. J. Wellens, and P. A. Doevendans, “17β-estradiol attenuates the development of pressure-overload hypertrophy,” Circulation, vol. 104, no. 12, pp. 1419–1423, 2001. View at Publisher · View at Google Scholar · View at Scopus
  121. M. R. Voss, J. N. Stallone, M. Li, R. N. M. Cornelussen, P. Knuefermann, and A. A. Knowlton, “Gender differences in the expression of heat shock proteins: the effect of estrogen,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 285, no. 2, pp. H687–H692, 2003. View at Google Scholar · View at Scopus
  122. A. A. Knowlton and L. Sun, “Heat-shock factor-1, steroid hormones, and regulation of heat-shock protein expression in the heart,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 280, no. 1, pp. H455–H464, 2001. View at Google Scholar · View at Scopus
  123. K. Rayner, J. Sun, Y.-X. Chen et al., “Heat shock protein 27 protects against atherogenesis via an estrogen-dependent mechanism: role of selective estrogen receptor beta modulation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 11, pp. 1751–1756, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. A. S. Al-Madhoun, Y.-X. Chen, L. Haidari et al., “The interaction and cellular localization of HSP27 and ERβ are modulated by 17β-estradiol and HSP27 phosphorylation,” Molecular and Cellular Endocrinology, vol. 270, no. 1-2, pp. 33–42, 2007. View at Publisher · View at Google Scholar · View at Scopus
  125. C. Borras, J. Gambini, M. C. Gómez-Cabrera et al., “17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade,” Aging Cell, vol. 4, no. 3, pp. 113–118, 2005. View at Google Scholar
  126. G. W. Dorn II, “Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling,” Cardiovascular Research, vol. 81, no. 3, pp. 465–473, 2009. View at Publisher · View at Google Scholar · View at Scopus
  127. R. S. Hotchkiss, A. Strasser, J. E. McDunn, and P. E. Swanson, “Cell death,” The New England Journal of Medicine, vol. 361, no. 16, pp. 1570–1583, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. G. Olivetti, R. Abbi, F. Quaini et al., “Apoptosis in the failing human heart,” The New England Journal of Medicine, vol. 336, no. 16, pp. 1131–1141, 1997. View at Google Scholar
  129. S. Hein, E. Arnon, S. Kostin et al., “Progression from compensated hypertrophy to failure in the pressure-overloaded human: heart structural deterioration and compensatory mechanisms,” Circulation, vol. 107, no. 7, pp. 984–991, 2003. View at Publisher · View at Google Scholar · View at Scopus
  130. M. M. Gallogly, M. D. Shelton, S. Qanungo et al., “Glutaredoxin regulates apoptosis in cardiomyocytes via NFκb targets Bcl-2 and Bcl-xl: implications for cardiac aging,” Antioxidants and Redox Signaling, vol. 12, no. 12, pp. 1339–1353, 2010. View at Publisher · View at Google Scholar · View at Scopus
  131. S. K. Kakarla, J. C. Fannin, S. Keshavarzian et al., “Chronic acetaminophen attenuates age-associated increases in cardiac ROS and apoptosis in the Fischer Brown Norway rat,” Basic Research in Cardiology, vol. 105, no. 4, pp. 535–544, 2010. View at Publisher · View at Google Scholar · View at Scopus
  132. V. Ljubicic, K. J. Menzies, and D. A. Hood, “Mitochondrial dysfunction is associated with a pro-apoptotic cellular environment in senescent cardiac muscle,” Mechanisms of Ageing and Development, vol. 131, no. 2, pp. 79–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  133. S. K. Kakarla, K. M. Rice, A. Katta et al., “Possible molecular mechanisms underlying age-related cardiomyocyte apoptosis in the F344XBN rat heart,” The Journals of Gerontology A: Biological Sciences and Medical Sciences, vol. 65, no. 2, pp. 147–155, 2010. View at Publisher · View at Google Scholar · View at Scopus
  134. Z. Mallat, P. Fornes, R. Costagliola et al., “Age and gender effects on cardiomyocyte apoptosis in the normal human heart,” Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 56, no. 11, pp. M719–M723, 2001. View at Publisher · View at Google Scholar · View at Scopus
  135. G. G. L. Biondi-Zoccai, A. Baldi, L. M. Biasucci, and A. Abbate, “Female gender, myocardial remodeling and cardiac failure: are women protected from increased myocardiocyte apoptosis?” Italian Heart Journal, vol. 5, no. 7, pp. 498–504, 2004. View at Google Scholar · View at Scopus
  136. M. Challah, S. Nadaud, M. Philippe et al., “Circulating and cellular markers of endothelial dysfunction with aging in rats,” American Journal of Physiology, vol. 273, no. 4, part 2, pp. H1941–H1948, 1997. View at Google Scholar · View at Scopus
  137. S. S. Najjar, A. Scuteri, and E. G. Lakatta, “Arterial aging: is it an immutable cardiovascular risk factor?” Hypertension, vol. 46, no. 3, pp. 454–462, 2005. View at Publisher · View at Google Scholar · View at Scopus
  138. D. H. O'Leary, J. F. Polak, R. A. Kronmal, T. A. Manolio, G. L. Burke, and S. K. Wolfson Jr., “Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults,” The New England Journal of Medicine, vol. 340, no. 1, pp. 14–22, 1999. View at Publisher · View at Google Scholar · View at Scopus
  139. A. U. Ferrari, A. Radaelli, and M. Centola, “Aging and the cardiovascular system,” Journal of Applied Physiology, vol. 95, no. 6, pp. 2591–2597, 2003. View at Google Scholar · View at Scopus
  140. S. J. Miller, W. C. Watson, K. A. Kerr et al., “Development of progressive aortic vasculopathy in a rat model of aging,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 293, no. 5, pp. H2634–H2643, 2007. View at Publisher · View at Google Scholar · View at Scopus
  141. W. Zhang, X. Zhang, and Y. Zhang, “Evaluation of thoracic aortic anatomy and function with transesophageal echocardiography,” Zhonghua Yi Xue Za Zhi, vol. 78, no. 9, pp. 666–669, 1998. View at Google Scholar · View at Scopus
  142. J. J. van der Heijden-Spek, J. A. Staessen, R. H. Fagard, A. P. Hoeks, H. A. Struijker Boudier, and L. M. Van Bortel, “Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study,” Hypertension, vol. 35, no. 2, pp. 637–642, 2000. View at Publisher · View at Google Scholar · View at Scopus
  143. P. Albaladejo, P. Laurent, B. Pannier, A. Achimastos, M. Safar, and A. Benetos, “Influence of sex on the relation between heart rate and aortic stiffness,” Journal of Hypertension, vol. 21, no. 3, pp. 555–562, 2003. View at Publisher · View at Google Scholar · View at Scopus
  144. H. Qiu, B. Tian, R. G. Resuello et al., “Sex-specific regulation of gene expression in the aging monkey aorta,” Physiological Genomics, vol. 29, no. 2, pp. 169–180, 2007. View at Publisher · View at Google Scholar · View at Scopus
  145. G. Gennaro, C. Ménard, E. Giasson et al., “Role of p44/p42 MAP kinase in the age-dependent increase in vascular smooth muscle cell proliferation and neointimal formation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 2, pp. 204–210, 2003. View at Publisher · View at Google Scholar · View at Scopus
  146. E. Porreca, R. Ciccarelli, C. Di Febbo, and F. Cuccurullo, “Protein kinase C pathway and proliferative responses of aged and young rat vascular smooth muscle cells,” Atherosclerosis, vol. 104, no. 1-2, pp. 137–145, 1993. View at Publisher · View at Google Scholar · View at Scopus
  147. R. J. Hariri, D. R. Alonso, D. P. Hajjar, D. Coletti, and M. E. Weksler, “Aging and arteriosclerosis. I. Development of myointimal hyperplasia after endothelial injury,” Journal of Experimental Medicine, vol. 164, no. 4, pp. 1171–1178, 1986. View at Publisher · View at Google Scholar · View at Scopus
  148. V. Sagach, A. Bondarenko, O. Bazilyuk, and A. Kotsuruba, “Endothelial dysfunction: possible mechanisms and ways of correction,” Experimental & Clinical Cardiology, vol. 11, no. 2, pp. 107–110, 2006. View at Google Scholar · View at Scopus
  149. T. Hayashi and A. Iguchi, “Possibility of the regression of atherosclerosis through the prevention of endothelial senescence by the regulation of nitric oxide and free radical scavengers,” Geriatrics and Gerontology International, vol. 10, no. 2, pp. 115–130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  150. D. M. Dudzinski and T. Michel, “Life history of eNOS: partners and pathways,” Cardiovascular Research, vol. 75, no. 2, pp. 247–260, 2007. View at Publisher · View at Google Scholar · View at Scopus
  151. F. M. Ho, W. W. Lin, B. C. Chen et al., “High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-κB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway,” Cellular Signalling, vol. 18, no. 3, pp. 391–399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  152. Y. C. Boo and H. Jo, “Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases,” The American Journal of Physiology—Cell Physiology, vol. 285, no. 3, pp. C499–C508, 2003. View at Publisher · View at Google Scholar · View at Scopus
  153. Y. Dohi, M. Kojima, K. Sato, and T. F. Luscher, “Age-related changes in vascular smooth muscle and endothelium,” Drugs and Aging, vol. 7, no. 4, pp. 278–291, 1995. View at Publisher · View at Google Scholar · View at Scopus
  154. J. Hoffmann, J. Haendeler, A. Aicher et al., “Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide,” Circulation Research, vol. 89, no. 8, pp. 709–715, 2001. View at Publisher · View at Google Scholar · View at Scopus
  155. R. P. Brandes, I. Fleming, and R. Busse, “Endothelial aging,” Cardiovascular Research, vol. 66, no. 2, pp. 286–294, 2005. View at Publisher · View at Google Scholar · View at Scopus
  156. J. H. Kim, L. J. Bugaj, J. O. Young et al., “Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats,” Journal of Applied Physiology, vol. 107, no. 4, pp. 1249–1257, 2009. View at Publisher · View at Google Scholar · View at Scopus
  157. S. Chakrabarti, O. Lekontseva, A. Peters, and S. T. Davidge, “17β-Estradiol induces protein S-nitrosylation in the endothelium,” Cardiovascular Research, vol. 85, no. 4, pp. 796–805, 2010. View at Publisher · View at Google Scholar · View at Scopus
  158. J. P. Stice, J. P. Eiserich, and A. A. Knowlton, “Role of aging versus the loss of estrogens in the reduction in vascular function in female rats,” Endocrinology, vol. 150, no. 1, pp. 212–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  159. J. Widder, T. Pelzer, C. von Poser-Klein et al., “Improvement of endothelial dysfunction by selective estrogen receptor-α stimulation in ovariectomized SHR,” Hypertension, vol. 42, no. 5, pp. 991–996, 2003. View at Publisher · View at Google Scholar · View at Scopus
  160. P. Angerer, S. Störk, W. Kothny, P. Schmitt, and C. Von Schacky, “Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: a randomized, controlled trial,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 2, pp. 262–268, 2001. View at Publisher · View at Google Scholar · View at Scopus
  161. S. Ling, A. Dai, R. J. Dilley et al., “Endogenous estrogen deficiency reduces proliferation and enhances apoptosis-related death in vascular smooth muscle cells: insights from the aromatase-knockout mouse,” Circulation, vol. 109, no. 4, pp. 537–543, 2004. View at Publisher · View at Google Scholar · View at Scopus
  162. E. Espinosa, E. Espinosa, B. S. Oemar, B. S. Oemar, T. F. Luscher, and T. F. Lüscher, “17β-estradiol and smooth muscle cell proliferation in aortic cells of male and female rats,” Biochemical and Biophysical Research Communications, vol. 221, no. 1, pp. 8–14, 1996. View at Publisher · View at Google Scholar · View at Scopus
  163. A. Suzuki, K. Mizuno, Y. Ino et al., “Effects of 17β-estradiol and progesterone on growth-factor-induced proliferation and migration in human female aortic smooth muscle cells in vitro,” Cardiovascular Research, vol. 32, no. 3, pp. 516–523, 1996. View at Publisher · View at Google Scholar · View at Scopus
  164. W.-S. Lee, J. A. Harder, M. Yoshizumi, M.-E. Lee, and E. Haber, “Progesterone inhibits arterial smooth muscle cell proliferation,” Nature Medicine, vol. 3, no. 9, pp. 1005–1008, 1997. View at Publisher · View at Google Scholar · View at Scopus
  165. C. Bolego, A. Cignarella, V. Zancan, C. Pinna, R. Zanardo, and L. Puglisi, “Diabetes abolishes the vascular protective effects of estrogen in female rats,” Life Sciences, vol. 64, no. 9, pp. 741–749, 1999. View at Publisher · View at Google Scholar · View at Scopus
  166. Q.-W. Chen, L. Edvinsson, and C.-B. Xu, “Role of ERK/MAPK in endothelin receptor signaling in human aortic smooth muscle cells,” BMC Cell Biology, vol. 10, article 52, 2009. View at Publisher · View at Google Scholar · View at Scopus
  167. T. Zou, W. Yang, Z. Hou, and J. Yang, “Homocysteine enhances cell proliferation in vascular smooth muscle cells: Role of p38 MAPK and p47phox,” Acta Biochimica et Biophysica Sinica, vol. 42, no. 12, pp. 908–915, 2010. View at Publisher · View at Google Scholar · View at Scopus
  168. I. Bhattacharya, M. Damjanović, A. Perez Dominguez, and E. Haas, “Inhibition of activated ERK1/2 and JNKs improves vascular function in mouse aortae in the absence of nitric oxide,” European Journal of Pharmacology, vol. 658, no. 1, pp. 22–27, 2011. View at Publisher · View at Google Scholar · View at Scopus
  169. K. M. Rice, E. M. Walker, S. K. Kakarla et al., “Fluprostenol-induced MAPK signaling is independent of aging in Fischer 344/NNiaHSd x Brown Norway/BiNia rat aorta,” Annals of Clinical and Laboratory Science, vol. 40, no. 1, pp. 26–31, 2010. View at Google Scholar · View at Scopus
  170. K. M. Rice, R. S. Kinnard, R. Harris, G. L. Wright, and E. R. Blough, “Effects of aging on pressure-induced MAPK activation in the rat aorta,” Pflügers Archiv, vol. 450, no. 3, pp. 192–199, 2005. View at Publisher · View at Google Scholar · View at Scopus
  171. A. J. Lusis, “Atherosclerosis,” Nature, vol. 407, no. 6801, pp. 233–241, 2000. View at Publisher · View at Google Scholar · View at Scopus
  172. N. K. Fukagawa, M. Li, C. R. Timblin, and B. T. Mossman, “Modulation of cell injury and survival by high glucose and advancing age,” Free Radical Biology & Medicine, vol. 31, no. 12, pp. 1560–1569, 2001. View at Publisher · View at Google Scholar · View at Scopus
  173. R. V. Sharma, M. V. Gurjar, and R. C. Bhalla, “Selected contribution: estrogen receptor-alpha gene transfer inhibits proliferation and NF-kappaB activation in VSM cells from female rats,” Journal of Applied Physiology, vol. 91, no. 5, pp. 2400–2389, 2001. View at Google Scholar · View at Scopus
  174. D. Xing, S. Nozell, Y. F. Chen, F. Hage, and S. Oparil, “Estrogen and mechanisms of vascular protection,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 3, pp. 289–295, 2009. View at Publisher · View at Google Scholar